These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2388101)

  • 1. Effects of calcium channel-blocking agents on platelet-osteogenic sarcoma interaction: platelet aggregation and electron microscopic findings.
    Mehta P; Kimura A; Lawson D
    J Orthop Res; 1990 Sep; 8(5):629-34. PubMed ID: 2388101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME; Renzulli LA
    Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
    Butt IF; Saeed SA; Waqar SN; Aslam M
    J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
    J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-aggregatory actions of calcium channel blockers in cat platelets.
    Schmunk GA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):179-87. PubMed ID: 6803310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
    Ivleva AIa; Kobalava ZhD; Moiseev VS
    Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.
    Walley TJ; Woods KL; Barnett DB
    Thromb Haemost; 1989 Feb; 61(1):137-9. PubMed ID: 2749586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis.
    Mehta P; Lawson D; Ward MB; Kimura A; Gee A
    Cancer Res; 1987 Jun; 47(12):3115-7. PubMed ID: 3472652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro.
    Wang LL; Mei QB; Zhao DH; Guo ZA
    Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobra venom cardiotoxin induces aggregation of washed rat platelets: dual effects of Ca2+.
    Huang SJ; Kwan CY
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):103-10. PubMed ID: 8948018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation by low-density lipoprotein and serotonin: effects of calcium antagonists.
    Fetkovska N
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S25-8. PubMed ID: 1376830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway.
    Cattaneo M; Mustard JF; Canciani MT; Richardson M; Federici AB; Mannucci PM
    Thromb Haemost; 1988 Oct; 60(2):280-8. PubMed ID: 3146144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.